ALUR Stock Analysis: Buy, Sell, or Hold?
ALUR - Allurion Technologies, Inc.
$0.67
-0.04 (-5.63%)
▼
5d:
-42.64%
30d:
-43.13%
90d:
-53.07%
WAIT
LOW Confidence
Analysis Updated: Mar 6, 2026 12:00 AM ET
Earnings: Mar 25, 2026
0d
Get Alerted When ALUR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ALUR is down 42.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ALUR is down 42.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ALUR is currently trading at $0.67, which is considered fair based on recent price action.
Technical Outlook: Technically, ALUR is in a strong downtrend. The price is currently testing key support at $0.65. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.6% recently.
Market Sentiment: ALUR has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.50 (+719.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ALUR is in a strong downtrend. The price is currently testing key support at $0.65. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.6% recently.
Market Sentiment: ALUR has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.50 (+719.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
49/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
39.5%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (25/100)
- BEARISH: Downward momentum (-5.6%)
- BULLISH: Trading 719.5% below Wall St target ($5.50)
Support & Resistance Levels
Support Level
$0.65
Resistance Level
$2.07
Current Trend
Strong Downtrend
Technical data as of
Mar 6, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.40
Wall Street Target
$5.50
(+719.5%)
Revenue Growth (YoY)
-50.5%
Earnings Growth (YoY)
7119.4%
Profit Margin
-187.9%
Share & Embed Analysis
Last updated: May 02, 2026 7:13 PM ET
Data refreshes hourly during market hours. Next update: 8:13 PM
Data refreshes hourly during market hours. Next update: 8:13 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALUR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Michael R Davin
SELL
1606 shares
2025-12-03
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$86 | 59 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$87 | 52 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 53 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$108 | 58 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 65 BUY |